Dr. Stephen Grubbs on Measuring Value in Oncology

Stephen S. Grubbs, MD,
Published: Thursday, Apr 21, 2016



Stephen S. Grubbs, MD, senior director of the new clinical affairs department of the American Society of Clinical Oncology (ASCO) discusses value-based oncology.

The field of oncology is moving toward a value-based system, where doctors will be gauged on the value on their care instead of individual components, says Grubbs. In the past oncology has mostly been a fee-for-service model.

In order for a value-based model to work, it must first be determined how value can be measured, he says. There must be a structured approach to how value will be measured in the long run.

ASCO is putting together a framework to determine how to define value. There is currently a framework that has been published, which is open for consideration, says Grubbs.

SELECTED
LANGUAGE


Stephen S. Grubbs, MD, senior director of the new clinical affairs department of the American Society of Clinical Oncology (ASCO) discusses value-based oncology.

The field of oncology is moving toward a value-based system, where doctors will be gauged on the value on their care instead of individual components, says Grubbs. In the past oncology has mostly been a fee-for-service model.

In order for a value-based model to work, it must first be determined how value can be measured, he says. There must be a structured approach to how value will be measured in the long run.

ASCO is putting together a framework to determine how to define value. There is currently a framework that has been published, which is open for consideration, says Grubbs.


View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Rapid Reviews in Oncology®: Practice-Changing Data in Acute Myeloid Leukemia: A Rapid Update From Atlanta OnlineDec 21, 20182.0
Community Practice Connections™: 2nd Annual European Congress on Hematology™: Focus on Lymphoid MalignanciesDec 30, 20182.0
Publication Bottom Border
Border Publication
x